| Literature DB >> 32179862 |
Xuemei Luo1, Jieqin Meng1, Xiufen Chen1, Liangke Cheng1, Shaopeng Yan1, Luying Gao1, Miao Xue1, Yaojun Yang2.
Abstract
Whitmania pigra, called Mahuang (MH) in Chinese, has been used as a traditional Chinese medicine for many years and is susceptible to Pb exposure in aquaculture environments. To understand the impact of Pb in the culture environment on MHs, we carried out a 50-day culture of MHs in environments with different levels of Pb pollution. Then, tissue samples of MHs reared in the different Pb-polluted environments were collected and analysed by UPLC-Q/TOF-MS. The results showed that the Pb residue in MHs increased with increasing Pb in the culture environment. There was no significant difference in MH Pb content (P < 0.05) between the low-Pb residue group (PbL) and the blank control group (BC), and those of the middle-Pb residue group (PbM) and the high-Pb residue group (PbH) were significantly different from that of the BC group. Metabolomics results showed significant changes in 24 metabolites in the PbL, PbM and PbH groups, some of which were dose-dependent. These metabolites were mainly lipids, nucleotides, and dipeptides, which are involved in metabolic pathways such as glycerophospholipid metabolism, sphingolipid metabolism, and nucleotide metabolism. Overall, the results proved that metabolomics can be an effective tool to understand the effects of Pb on the metabolic responses of MHs.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32179862 PMCID: PMC7075881 DOI: 10.1038/s41598-020-61745-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Pb residues in MH under different culture environments (n = 4, ± s).
| Group | Pb residual(mg·kg−1) |
|---|---|
| Blank control (BC) | 2.05 ± 0.84 |
| Pb low residue (PbL) | 3.185 ± 1.63 |
| Pb low residue (PbM) | 6.46 ± 3.25* |
| Pb low residue (PbH) | 10.66 ± 2.79* |
*Indicates a significant difference compared to the BC group, P < 0.05.
Figure 1Base peak ion (BPI) chromatogram of tissue samples in each group in positive and negative ion mode. (A) BC group; (B) PbL group; (C) PbM group; (D) PbH group. These figures were created with Masslynx (version 4.1, https://www.waters.com/).
Figure 2PCA score plots of MH tissue metabolites in positive (A) and negative (B) ion modes. These figures were created with SIMCA (version 14.1, http://www.umetrics.com/simca).
Figure 3OPLS-DA score plots of MH tissue metabolites in positive ion (A) and negative ion (B) modes. The 200-time permutation test of the OPLS-DA model in positive ion (C) and negative ion (D) modes. These figures were created with SIMCA (version 14.1, http://www.umetrics.com/simca).
Characteristic information of differential metabolites of MH in Pb-contaminated environment.
| NO. | Iron mode | classification | metabolites | Formula | RT/s | m/z | VIP scorea | P-valuea | Up or downa |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ESI+ | PE(14:0/14:0) | C33H66NO8P | 13.53 | 699.4705 | 3.26 | 0.0036 | ↓ | |
| 2 | ESI+ | LPE(24:6) | C29H48NO7P | 12.35 | 518.3062 | 1.10 | 0.0266 | ↓ | |
| 3 | ESI+ | LPE(18:1) | C23H46NO7P | 12.60 | 524.2758 | 1.73 | 0.0048 | ↓ | |
| 4 | ESI+ | Phosphorylcholine | C5H15NO4P | 0.97 | 184.0689 | 4.76 | 3.18E-07 | ↓ | |
| 5 | ESI− | Phosphatidylserine(28:2) | C34H62NO10P | 9.63 | 656.393 | 1.88 | 0.03023 | ↓ | |
| 6 | ESI+ | Sphinganine | C18H39NO2 | 10.89 | 274.2711 | 2.00 | 0.0110 | ↓ | |
| 7 | ESI+ | Phytosphingosine | C18H39NO3 | 10.86 | 318.3058 | 2.02 | 0.0247 | ↓ | |
| 8 | ESI+ | Cardiolipin(65:2) | C74H140O17P2 | 10.54 | 1376.9655 | 1.72 | 0.0024 | ↓ | |
| 9 | ESI+ | Tracylglycerol (61:3) | C64H118O6 | 10.44 | 996.8949 | 1.55 | 0.0208 | ↓ | |
| 10 | ESI+ | Triacylglycerol(71:0) | C74H144O6 | 10.68 | 1143.1074 | 1.19 | 0.0393 | ↓ | |
| 11 | ESI+ | Diacylglycerol(33:0) | C36H70O5 | 21.45 | 615.5587 | 1.66 | 0.0430 | ↓ | |
| 12 | ESI− | Diacylglycerol(42:1) | C45H86O5 | 10.43 | 1412.2859 | 1.38 | 0.0276 | ↓ | |
| 13 | ESI− | Uridine 2′-phosphate | C9H13N2O9P | 1.07 | 323.031 | 1.26 | 0.0196 | ↑ | |
| 14 | ESI+ | 2′,3′-Cyclic UMP | C9H11N2O8P | 1.04 | 348.0616 | 1.96 | 0.0013 | ↓ | |
| 15 | ESI+ | Adenosine 5′-monophosphate | C10H14N5O7P | 1.09 | 348.0613 | 2.00 | 0.0332 | ↓ | |
| 16 | ESI+ | Cytidine monophosphate N-acetylneuraminic acid | C12H16N2O3S | 11.36 | 1251.2936 | 2.00 | 0.0005 | ↑ | |
| 17 | ESI− | Glutamylmethionine | C10H18N2O5S | 7.71 | 243.0775 | 1.63 | 0.0476 | ↑ | |
| 18 | ESI+ | Histidinyl-Isoleucine | C12H20N4O3 | 8.49 | 559.3003 | 2.68 | 0.0117 | ↑ | |
| 19 | ESI+ | Phenylalanyl-Tryptophan | C20H21N3O3 | 7.96 | 393.1945 | 1.62 | 0.0281 | ↓ | |
| 20 | ESI+ | Cysteinyl-Phenylalanine | C12H16N2O3S | 1.05 | 301.1234 | 1.94 | 0.0001 | ↓ | |
| 21 | ESI− | Methionyl-Serine | C8H16N2O4S | 1.08 | 273.0322 | 2.06 | 0.0332 | ↑ | |
| 22 | ESI− | Valyl-Arginine | C11H23N5O3 | 7.92 | 272.1746 | 1.32 | 0.0477 | ↓ | |
| 23 | ESI− | Farnesyl pyrophosphate | C15H28O7P2 | 9.13 | 427.1314 | 1.44 | 0.0040 | ↓ | |
| 24 | ESI− | N-Acetyl-D-Glucosamine 6-Phosphate | C8H16NO9P | 1.04 | 300.0468 | 1.24 | 0.0062 | ↑ |
aThe results of the group exhibiting the greatest change in the metabolite was compared with that in the BC group when the metabolite did not change in a dose-dependent manner, otherwise indicating the compared results of PbH with BC.
Figure 4Metabolic pathway impact map of Pb on MHs. (A) Glycerophospholipid metabolism; (B) sphingolipid metabolism; (C) terpenoid backbone biosynthesis; (D) purine metabolism. This figure was created with MetaboAnalyst (version 4.0 http://www.metaboanalyst.ca/).
Figure 5Changes in potential biomarkers in the BC, PbL, PbM and PbL groups.